Description

The Alcohol Use Blood Panel is designed to evaluate the physiological impact of alcohol consumption and screen for complications related to Alcohol Use Disorder (AUD). By monitoring key biomarkers, this panel helps detect nutritional deficiencies, liver dysfunction, and blood abnormalities commonly seen in chronic or excessive alcohol use. It plays a vital role in diagnosis, treatment planning, and ongoing management.

Why This Panel Is Important:

  • Detects early signs of alcohol-related health complications
  • Supports the diagnosis and monitoring of Alcohol Use Disorder (AUD)
  • Helps prevent long-term consequences such as liver disease, neurological damage, and nutrient deficiencies
  • Aids in the development of personalized treatment plans and recovery monitoring

Biomarkers Included in This Panel:

1. Complete Blood Count (CBC):

  • Assesses red blood cells, white blood cells, and platelets
  • Detects anemia and macrocytosis, both common in chronic alcohol use
  • May reveal signs of bone marrow suppression or infection

2. Hepatic (Liver) Panel:

  • Measures ALT, AST, ALP, bilirubin, and other enzymes
  • Evaluates liver inflammation, injury, or dysfunction
  • Helps detect conditions such as fatty liver disease, alcoholic hepatitis, and cirrhosis

3. Magnesium:

  • Alcohol impairs magnesium absorption and increases excretion
  • Deficiency may cause muscle cramps, fatigue, seizures, and cardiac arrhythmias

4. PEth (Phosphatidylethanol):

  • A direct biomarker of recent alcohol use
  • Formed only in the presence of ethanol, detectable for up to 2–4 weeks
  • Useful for monitoring sobriety, relapse detection, and treatment compliance

5. Vitamin B1 (Thiamine):

  • Essential for brain and nerve function
  • Deficiency may lead to Wernicke’s encephalopathy and Korsakoff syndrome
  • Critical to assess in individuals with chronic alcohol consumption

6. Vitamin B12:

  • Important for nervous system health and red blood cell production
  • Alcohol impairs absorption, leading to neurological symptoms and megaloblastic anemia

Fasting Requirement:

  • Fasting is NOT required
  • Testing can be performed at any time of day

Ideal For:

  • Individuals with known or suspected alcohol use issues
  • Patients in rehabilitation or recovery programs
  • Routine monitoring of individuals at risk for alcohol-related complications
  • Establishing baseline health before initiating treatment for AUD